Overview of Low Grade Gliomas 

A review of current knowledge reveals that a comprehensive genomic characterization of the evolution from primary low-grade glioma to recurrence is needed to advance treatment. Engagement with persons living with LGG is key to this effort.
Learning Objectives:
• Understand the new, 2021, World Health Organization (WHO) guidelines for LGG
• Understand genetic and environmental risk factors for glioma
• Learn about new research into LGG and the role of patient engagement in this effort
Presented by:
Elizabeth Claus, PhD, MD,
Brigham and Women’s Hospital,
Yale University School of Public Health,
Principal Investigator LGG Registry, OPTIMUM
Liz Salmi
Researcher, Beth Israel Deaconess Medical
~Video Contents~
00:00 Introduction
01:01 Distribution of Brain Tumor Diagnoses
02:29 Old Classification of Gliomas
05:21 New WHO 2021 Updates to Classification of Gliomas
09:43 Glioma Risk Factors
17:45 Low Grade Glioma Research
28:45 Liz Salmi Intro
30:55 Liz Samli's Brain Tumor Experience
32:12 How to Engage in Research
38:03 Q&A
Download our Resource Handout for more resources and information on Low Grade Gliomas: bit.ly/2023PFMResourceHandout
For more information, resources or support, visit the abta.org, call (800) 886-2282 or email info@abta.org.